SCHEMBL18669052

SCHEMBL18669052

O=C1c2ccccc2C(=O)N1CCc1ccc(Cl)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 1/20 0.65
▸ CA1 P00915 1/20 0.62
▸ CA2 P00918 1/20 0.62
▸ CA4 P22748 1/20 0.62
▸ CA9 Q16790 1/20 0.62
▸ ADRA1D P25100 2/20 0.60
▸ ADRA1A P35348 2/20 0.60
▸ ADRA1B P35368 2/20 0.60
▸ TDP1 Q9NUW8 2/20 0.58
▸ MAPT P10636 3/20 0.57
▸ ALDH1A1 P00352 3/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ GAA P10253 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ ALDH2 P05091 1/20 0.54
▸ ALDH3A1 P30838 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3745584 0.94 CASP3 (0.77) CASP3CA1CA2CA4CA9
SCHEMBL5422820 0.90 TDP1 (0.66) ADRA1DADRA1AADRA1BTDP1L3MBTL1
SCHEMBL1142116 0.85 CASP3 (0.86) CASP3CA1CA2CA4CA9
SCHEMBL29724090 0.85 CASP3 (0.86) CASP3CA1CA2CA4CA9
SCHEMBL18074272 0.84 CASP3 (0.67) CASP3CA1CA2CA4CA9
SCHEMBL18668950 0.83 CES2 (0.67) CASP3CA1CA2CA9ADRA1D
SCHEMBL4597126 0.82 ALDH1A1 (0.77) CASP3TDP1MAPTALDH1A1ALDH2
SCHEMBL1430310 0.82 CASP3 (0.65) CASP3CA1CA2CA4CA9
SCHEMBL3175301 0.82 CASP3 (0.65) CASP3CA1CA2CA4CA9
SCHEMBL7954280 0.82 CASP3 (0.65) CASP3CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 — — WO disclosed
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 — — WO disclosed
Send feedback